- Home
- AKTX vs NIXX Comparison
AKTX vs NIXX Comparison
Compare AKTX & NIXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- NIXX
- Stock Information
- Founded
- AKTX N/A
- NIXX 2010
- Country
- AKTX United States
- NIXX United States
- Employees
- AKTX N/A
- NIXX N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- NIXX
- Sector
- AKTX Health Care
- NIXX
- Exchange
- AKTX Nasdaq
- NIXX NYSE
- Market Cap
- AKTX 41.8M
- NIXX 39.8M
- IPO Year
- AKTX N/A
- NIXX N/A
- Fundamental
- Price
- AKTX $1.18
- NIXX $1.80
- Analyst Decision
- AKTX
- NIXX
- Analyst Count
- AKTX 0
- NIXX 0
- Target Price
- AKTX N/A
- NIXX N/A
- AVG Volume (30 Days)
- AKTX 27.5K
- NIXX 258.1K
- Earning Date
- AKTX 08-18-2025
- NIXX 08-13-2025
- Dividend Yield
- AKTX N/A
- NIXX N/A
- EPS Growth
- AKTX N/A
- NIXX N/A
- EPS
- AKTX N/A
- NIXX N/A
- Revenue
- AKTX N/A
- NIXX $1,786,387.00
- Revenue This Year
- AKTX N/A
- NIXX N/A
- Revenue Next Year
- AKTX N/A
- NIXX N/A
- P/E Ratio
- AKTX N/A
- NIXX N/A
- Revenue Growth
- AKTX N/A
- NIXX 54.16
- 52 Week Low
- AKTX $0.85
- NIXX $1.35
- 52 Week High
- AKTX $4.40
- NIXX $8.50
- Technical
- Relative Strength Index (RSI)
- AKTX 44.68
- NIXX N/A
- Support Level
- AKTX $1.09
- NIXX N/A
- Resistance Level
- AKTX $1.22
- NIXX N/A
- Average True Range (ATR)
- AKTX 0.08
- NIXX 0.00
- MACD
- AKTX -0.00
- NIXX 0.00
- Stochastic Oscillator
- AKTX 40.00
- NIXX 0.00
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.